1. A PHASE IIA STUDY EVALUATING THE SAFETY AND TOLERABILITY OF UMBRALISIB AND IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Lunning, M.; Bierman, P.; Bociek, R.; Armitage, J.; Heires, P.; Blumel, S.; Hohenstein, M.; Lyden, L.; Vose, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗